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Background
Patients referred to cardiac MRI (CMR) for suspicion of
obstructive coronary artery disease typically undergo
vasodilator stress testing using either adenosine or rega-
denoson. Both of these agents are effective and have
been evaluated for stress testing in both the CMR and
nuclear medicine setting but the cardiovascular physio-
logic effects of each of these agents have not been well
studied. Despite different pharmacokinetics, stress CMR
protocols do not differ between agents, and it is truly
unknown if the agents alter ventricular volumes, func-
tion and flow differently. In this study, we evaluated the
physiologic cardiovascular effects of each of these agents
over time in healthy volunteers.
Methods
We performed a prospective non-randomized controlled
trial of 25 healthy volunteers undergoing stress CMR.
Vital signs, ventricular volumes, pulmonic and aortic flow
were measured at baseline and immediately following
infusion of adenosine (140mcg/kg/min IV for 6 minutes)
and at 5, 10, and 15 minutes after infusion utilizing a
1.5T MRI Scanner (Siemens Espree) and 32 channel coil
(Siemens Tim). Following a 10 minute rest period the
same protocol was performed utilizing a standard dose of
regadenoson (0.4mg IV over 10 seconds). A survey of
side effects, medication tolerance and drug preference
was given at the end of exam. All measurements were
performed utilizing QMass (Vital Imaging, 2014).
Results
At 5 minutes following infusion, adenosine had a more
significant effect on biventricular volumes with up to a
20% increase seen when compared to regadenoson and
continued to remain elevated at 15 minutes. Right and
left ventricular ejection fractions increased by 5% at 15
minutes after adenosine infusion while the RVEF
increased by 4% and LVEF reduced by 3% at 15 minutes
following regadenoson dosing. Cardiac output immedi-
ately increased by 28% following adenosine while rela-
tively unchanged by regadenoson. Both pulmonary
arterial and aortic peak velocities were reduced on aver-
age of 0.5 m/sec at 5 minutes with each agent and
returned to baseline values at 15 minutes. Heart rate
and blood pressure returned to baseline with both
agents at 15 minutes. Overall, study subjects preferred
adenosine over regadenoson citing preference of adeno-
sine’s slow onset and rapid taper of side effects rather
than the sudden onset and slow taper of side effects
with regadenoson.
Conclusions
Contrary to popular belief, both adenosine and regadeno-
son have significant and protracted effects on cardiac
physiology despite return of vital signs to baseline. When
compared to regadenoson, adenosine’s effects on right
and left ventricular volumes are much more significant
yet both have minimal effect on outflow peak velocities.
In the end, consideration should be given to timing of
administration of each vasodilating agent and patient
comfort when planning stress-CMR protocols.
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